interaksiSSS2011

Embed Size (px)

Citation preview

  • 8/2/2019 interaksiSSS2011

    1/7

    1. Intranasal Mometasone

    Adult Dosing & Uses

    Dosing Forms & Strengths

    nasal spray suspension

    50mcg/spray

    Allergic Rhinitis

    Indicated for treatment of nasal symptoms of allergic rhinitis

    2 sprays (100 mcg) in each nostril qDay

    Seasonal Allergic Rhinitis

    Indicated for treatment of nasal congestion associated with seasonal allergic rhinitis;

    also indicated for prophylaxis of seasonal allergic rhinitis

    Treatment: 2 sprays (100 mcg) in each nostril qDay

    Prophylaxis: 2 sprays (100 mcg) in each nostril qDay; initiate 2-4 weeks prior to allergy

    season

    Nasal Polyps

    2 sprays (100 mcg) in each nostril BID; qDay dosing may be effective in some patients

    Pharmacology

    Minimal systemic absorption occurs, mostly by small amount swallowed during nasal

    administration

    Bioavailability:

  • 8/2/2019 interaksiSSS2011

    2/7

    2. Chlorpheniramine

    Adult Dosing & Uses

    Dosing Forms & Strengths

    tablet

    4mg

    8mg

    12mg

    Allergic Rhinitis

    Tablets or syrup: 4 mg q4-6hr; not to exceed 24 mg/24 hours

    Extended-release tablets: 8 mg q8-12hr or 12 mg q12hr; not to exceed 24 mg/24 hours

    Extended-release capsules: 12 mg PO qDay; not to exceed 24 mg/24 hours

    Sustained-release capsules: 8-12 mg q12hr, up to 16-24 mg/day

    Additional Information

    See also combo with hydrocodone (Tussionex)

    Other Indications & Uses

    Perennial & seasonal allergic & vasomotor rhinitis, relief of symptoms from colds,

    urticaria, angioedema, anaphylactic reactions, pruritus, allergic conjunctivitis

    Pharmacology

    Half-Life: 12-43 hr

    Duration: 24 hr

    Onset: 6 hr

    Peak Plasma Time: 2-6 hr

    Protein Bound: 69-72%

    Vd: 2.5-3.2 L/kg

    Metabolism: GI mucosa, liver

  • 8/2/2019 interaksiSSS2011

    3/7

    Metabolites: monodesmethylchlorpheniramine, didesmethylchlorpheniramine

    Excretion: urine

    Sedative effect: low

    Antihistamine activity: moderate

    Anticholinergic acitivity: moderate

    Mechanism of Action

    Histamine H1-receptor antagonist

    3. Pseudoephedrine (Sudafed) = Decongestant

    Adult Dosing & Uses

    Dosing Forms & Strengths

    tablet

    15mg

    30mg

    60mg

    120mg

    syrup, Peds

    3mg/mL

    Nasal Congestion

    60 mg PO q6hr PRN

    Time release: 120 mg PO BID

    Priapism (Off-label)

    60-120 mg PO

    See Also Combos

    with fexofenadine

    with desloratadine

    with loratadine

  • 8/2/2019 interaksiSSS2011

    4/7

    Other Indications & Uses

    Eustachian tube congestion

    Off-label: low-flow priapism

    Pharmacology

    Absorption: minimal systemic

    Half-Life: 5-8 hr

    Onset: 30 min

    Duration

    60 mg: 4-6 hr

    120 mg: 12 hr

    Peak Plasma

    Time: 1.97 hr

    Concentration: 422 ng/mL

    Other Information

    Metabolism: liver, by N-demethylation

    Metabolites: inactive

    Clearance: 7.3-7.6 mL/min/kg

    Excretion: urine

    Mechanism of Action

    Alpha adrenergic agonist

    4. Paracetamol (Acetaminophen)

    Adult Dosing & Uses

    Dosing Forms & Strengths

    (tablet)

  • 8/2/2019 interaksiSSS2011

    5/7

    325mg

    500mg

    (capsule)

    500 mg

    (caplet, extended-release)

    650 mg

    (tablet, chewable)

    80mg

    160mg

    (tablet, oral-disintegrating)

    80mg

    160mg

    (oral solution/suspension)

    160mg/5mL

    (suppository rectal)

    120 mg

    325 mg

    650 mg

    Analgesia & Fever

    Immediate-release: 325-650 mg PO/PR q4hr PRN, or 500 mg PO q8hr PRN

    Extended-release: 2 capsules (1300 mg) PO q8hr PRN

    Maximum dose

    Acetaminophen containing products: Not to exceed a cumulative dose of

    4 g/day of acetaminophen

    Tylenol Extra-Strength (ie, 500 mg/tab or cap): Not to exceed 3 g/day (6

    tabs or caps)

    See Also Combo

    Acetaminophen Combos

    Acetaminophen & NSAIDs

  • 8/2/2019 interaksiSSS2011

    6/7

    Renal Impairment

    CrCl 10-50 mL/min: give q6hr

    CrCl

  • 8/2/2019 interaksiSSS2011

    7/7